Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases

MLA

S.A. Dudley, et al. “Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases.” American Journal of Clinical Oncology, vol. 44, Sept. 2021, pp. 588–95. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....405d5b44e764e79b7187ca8ab90dc783&authtype=sso&custid=ns315887.

APA

S.A. Dudley, Scott G. Soltys, Kira Seiger, Jacob Wynne, Steven D. Chang, Leslie A. Modlin, Elham Rahimy, John R. Adler, Rie von Eyben, Erqi L. Pollom, Steven L. Hancock, Lisa R Jacobs, Clara Y.H. Choi, Iris C. Gibbs, Dylann Fujimoto, & Gordon Li. (2021). Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases. American Journal of Clinical Oncology, 44, 588–595.

Chicago

S.A. Dudley, Scott G. Soltys, Kira Seiger, Jacob Wynne, Steven D. Chang, Leslie A. Modlin, Elham Rahimy, et al. 2021. “Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities From Large Brain Metastases.” American Journal of Clinical Oncology 44 (September): 588–95. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....405d5b44e764e79b7187ca8ab90dc783&authtype=sso&custid=ns315887.